Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GSK205 is a selective TRPV4 antagonist (IC50: 4.19 μM) for inhibiting TRPV4-mediated Ca2+ influx.
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
2 mg | ¥ 987 | 5日内发货 | ||
25 mg | ¥ 7,690 | 6-8周 | ||
50 mg | ¥ 9,990 | 6-8周 | ||
100 mg | ¥ 17,500 | 6-8周 |
产品描述 | GSK205 is a selective TRPV4 antagonist (IC50: 4.19 μM) for inhibiting TRPV4-mediated Ca2+ influx. |
靶点活性 | TRPV4:4.19 μM |
体外活性 | GSK205 (5 μM; 4 days; T3-F442A adipocytes) treatment results in increases expression of thermogenic genes (Mcp1, Mip1α, Mcp3, Rantes and Vcam, et al.) and is also accompanied by a decrease in the proinflammatory gene program. This shift resembles the gene expression changes seen in TRPV4-deficient adipocytes.GSK205 (100 μM) potently antagonizes TRPV4 in 3T3-F442A adipocytes, as it effectively blocks the calcium influx caused by TRPV4 agonist. |
体内活性 | GSK205 treatment causes a reduced expression of the proinflammatory chemokines, macrophage marker and Tnfa in the EPI fat.?GSK205 treatment significantly improves glucose tolerance in diet-induced obese (DIO) mice.?There are no apparent sign of sickness or weight loss.??GSK205 has a relatively short half-life of 2 hours in the plasma and adipose tissues.GSK205 (10 mg/kg; intraperitoneal injection; twice daily; for 7 days; for 4 weeks; male C57BL/6J mice) treatment shows significantly increases expression of thermogenic genes such as Ucp1, Pgc1a, Cidea and Cox8b. |
分子量 | 481.45 |
分子式 | C24H25BrN4S |
CAS No. | 1263068-83-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 250 mg/mL (519.26 mM), Sonication is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.0771 mL | 10.3853 mL | 20.7706 mL | 51.9265 mL |
5 mM | 0.4154 mL | 2.0771 mL | 4.1541 mL | 10.3853 mL | |
10 mM | 0.2077 mL | 1.0385 mL | 2.0771 mL | 5.1926 mL | |
20 mM | 0.1039 mL | 0.5193 mL | 1.0385 mL | 2.5963 mL | |
50 mM | 0.0415 mL | 0.2077 mL | 0.4154 mL | 1.0385 mL | |
100 mM | 0.0208 mL | 0.1039 mL | 0.2077 mL | 0.5193 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
GSK205 1263068-83-2 Others GSK 205 GSK-205 Inhibitor inhibitor inhibit